Femasys (FEMY) FCF Margin Growth (5y) (2026)
Analysis
Femasys (FEMY) FCF Margin Growth (5y) (2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.23 Bn | 175.63 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.53 Bn | 122.31 Bn | 1.96 Bn |
| 3 | Medtronic | 117.08 Bn | 108.26 Bn | 6.34 Bn |
| 4 | Stryker | 105.08 Bn | 101.60 Bn | 4.50 Bn |
| 5 | Boston Scientific | 64.51 Bn | 63.97 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.91 Bn | 45.66 Bn | 1.35 Bn |
| 7 | Alcon | 33.07 Bn | 31.61 Bn | 1.68 Bn |
| 8 | Dexcom | 32.35 Bn | 30.40 Bn | 830.00 Mn |
| 9 | Steris | 20.78 Bn | 20.30 Bn | 684.20 Mn |
| 10 | Femasys | 9.52 Mn | 8.07 Mn | 189,391.00 |